Guideline on the use of porcine trypsin used in the manufacture of human biological medicinal products

We have adopted this International Scientific Guideline - EMA/CHMP/BWP/814397/2011

Last updated

28 August 2024

About this guideline

Overseas effective date: 1 September 2014

Categories: Biologicals | Finished product | Adventitious agents safety evaluation

TGA Annotations: Nil

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.

Product types